BlinkLab Ltd
BB1
Company Profile
Business description
BlinkLab Ltd is a company that has the license to commercialize the Licensed IP and has developed a smartphone-based application with an e-platform that serves as a medical device to perform neurometric tests to aid in the diagnosis of ASD, ADHD, schizophrenia, and other neurodevelopmental conditions. The results from the BlinkLab Tests are recorded by smartphone and uploaded to BlinkLab’s confidential and secure online platform where the data is analyzed.
Contact
216 Street Georges Tce
Level 4
PerthWA6000
AUST: +61 862682641
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Will China strong arm BHP into lower iron ore prices?
Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.
stocks
Chart of the Week: Where Morningstar sees attractive dividend yields in 26/27
Charts from the Australian Dividend Outlook show the sectors where they are abundant.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,287.10 | 9.40 | -0.10% |
| CAC 40 | 8,060.13 | 85.28 | 1.07% |
| DAX 40 | 24,597.13 | 211.35 | 0.87% |
| Dow JONES (US) | 46,601.78 | 1.20 | -0.00% |
| FTSE 100 | 9,548.87 | 65.29 | 0.69% |
| HKSE | 26,829.46 | 128.31 | -0.48% |
| NASDAQ | 23,043.38 | 255.02 | 1.12% |
| Nikkei 225 | 47,734.99 | 215.89 | -0.45% |
| NZX 50 Index | 13,611.09 | 42.61 | 0.31% |
| S&P 500 | 6,753.72 | 39.13 | 0.58% |
| S&P/ASX 200 | 8,983.60 | 11.40 | -0.13% |
| SSE Composite Index | 3,882.78 | 20.25 | 0.52% |